Home Analyst Ratings

Analyst Ratings

Random

Analyst Upgrades – Paylocity (NASDAQ:PCTY) Stock Gets Upgraded By SunTrust Banks from Hold to Buy

ME Staff - March 12, 2018

Analyst Upgrades – Johnson Matthey PLC (LON:JMAT) Stock Gets Upgraded By Barclays PLC from Overweight to

Analyst Activity – Robert W. Baird Reiterates Buy on NASDAQ:JNCE – Jounce Therapeutics (NASDAQ:JNCE)

Amazon.com, Inc. (NASDAQ:AMZN) price target raised to $2,100.00 by Telsey Advisory Group

Analyst Downgrades – Teck Resources (NYSE:TECK) Stock Gets Downgraded By Macquarie...

ME Staff - February 20, 2018

ME Staff - January 23, 2018

Analyst Downgrades – Gerdau (NYSE:GGB) Stock Gets Downgraded By Morgan Stanley...

ME Staff - March 8, 2018

Analyst Activity – J P Morgan Chase & Co Raises Its...

ME Staff - August 1, 2017

Analyst Activity – Cowen Reiterates Outperform on CVS Health (NYSE:CVS)

ME Staff - January 18, 2018

Analyst Activity – Credit Suisse Group Reiterates Underperform on Alliance Data...

ME Staff - January 17, 2018

Analyst Upgrades – NYSE:AMC – AMC Entertainment (NYSE:AMC) Stock Gets Upgraded...

ME Staff - May 8, 2018

Analyst Upgrades – Exelon Corporation (NYSE:EXC) Stock Gets Upgraded By Citigroup...

ME Staff - July 27, 2017

Analyst Activity – Royal Bank of Canada Reiterates Buy on NYSE:FCB...

ME Staff - April 26, 2018

Analyst Upgrades – Aratana Therapeutics (NASDAQ:PETX) (NASDAQ:PETX) Stock Gets Upgraded By...

ME Staff - March 27, 2018

12 3...2,111 Page 1 of 2,111

/* */

EDITOR PICKS

Market Morning: JD CEO Sued, Qualcomm Wins While Intel Exits, Fink...

April 17, 2019

Cannabis Stock News Daily Roundup April 17

April 17, 2019

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.